HENDERSON JANE (Chief Financial Officer) reported 1 transaction at APOGEE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/3/2026ACC: 0001140361-26-035611
Officer· Chief Financial Officer
Since Mar 2026
-542.37K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
542.37K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−158.37K
Price / share
—
Trade value
—
% of position
New position
9/3/2026
158.37K→0.00
Total
Net shares
−158.37K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/3/2026 | D · Disposition | −158.37K | — | — | New position | 158.37K | 0.00 |
| Total | −158.37K | $0.00 | ||||||
Derivative Transactions3
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
175.34K shares
Shares
−175.34K
Strike price
22.86
Held after
0.00
Exercisable
—
9/3/2026
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
124.96K shares
Shares
−124.96K
Strike price
49.07
Held after
0.00
Exercisable
—
9/3/2026
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
83.69K shares
Shares
−83.69K
Strike price
75.78
Held after
0.00
Exercisable
—
9/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock175.34K shares | 9/3/2026 | D · Disposition | −175.34K | 22.86 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock124.96K shares | 9/3/2026 | D · Disposition | −124.96K | 49.07 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock83.69K shares | 9/3/2026 | D · Disposition | −83.69K | 75.78 | — | 0.00 |